Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
4,058
Views
3
CrossRef citations to date
0
Altmetric
Genetic Disease

Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis

Jaime L. Rubina Vertex Pharmaceuticals Incorporated, Boston, MA, USACorrespondence[email protected]
,
Andrea Lopeza Vertex Pharmaceuticals Incorporated, Boston, MA, USA
,
Jason Bootha Vertex Pharmaceuticals Incorporated, Boston, MA, USA
,
Penilla Guntherb Former Member of Swedish Parliament, Stockholm, Sweden
&
Anupam B. Jenac Harvard Medical School, Boston, MA, USA
Pages 783-791 | Received 29 Mar 2022, Accepted 11 May 2022, Published online: 09 Jun 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.